Fig. 2From: Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapyPharmacokinetics analysis of single dosage of rHSA/G-CSF (a) and double dosage of rHSA/G-CSF (b) from dose-escalation phase 1b trialBack to article page